# Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin

> **NCT02508090** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 10 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02508090
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08-02
- **Primary completion:** 2017-01-13
- **Final completion:** 2017-01-13
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-11-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02508090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02508090, "Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02508090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*